LOCALLY ADVANCED SOLID TUMOR
Clinical trials for LOCALLY ADVANCED SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Cancer's 'Don't eat Me' signal in early trial
Disease control OngoingThis early-phase study tests a new drug, NTX-1088, which blocks a protein on cancer cells that helps them hide from the immune system. The trial includes about 90 adults with advanced solid tumors that have not responded to standard treatments. Participants receive NTX-1088 alone…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1 • Sponsor: Nectin Therapeutics Ltd • Aim: Disease control
Last updated May 26, 2026 04:07 UTC
-
New cancer drug TST003 enters human trials for advanced tumors
Disease control OngoingThis study tests a new drug called TST003 in about 111 people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check side effects, and see if the drug can shrink tumors. Participants receive the drug through a ve…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests an experimental drug called TransCon IL-2 β/γ, given alone or with other cancer treatments, for adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find safe doses and check for side effects. About 320 partici…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated May 22, 2026 13:53 UTC